GLP-1 medications mimic a hormone naturally produced in the gut, helping the body: Increase insulin secretion in response to meals Slow gastric emptying Suppress appetite and reduce cravings These mechanisms support a caloric deficit and help many patients lose weight when combined with lifestyle changes
Extracellular plasma GPx (pGPx or GPx3) is mainly expressed by the kidney from where it is released into the blood circulation
if you expose it to liquid too forcefully or shake it violently, you risk damaging the molecular structure (denaturation), which can undermine research quality
if you become pregnant whilst on treatment, stop the medication and seek immediate medical and nutritional review [1] [25] Contact your GP urgently if you experience: Severe, persistent abdominal pain (with or without vomiting) which could indicate pancreatitis Upper-right abdominal pain, fever or jaundice which may suggest gallbladder disease Persistent nausea or vomiting preventing adequate nutrition Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained symptoms such as jaundice, severe fatigue, or mood changes For people with diabetes: hypoglycaemia (low blood sugar) symptoms when taking insulin or sulfonylureas alongside GLP-1 therapy Regular monitoring throughout GLP-1 treatment should include periodic assessment of weight, body composition where possible, nutritional intake, and relevant blood markers
Zhang, Y., Xu, P., Xue, W., Zhu, W